T1	Participants 0 134	Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin
T2	Participants 148 191	An Eastern Cooperative Oncology Group study
T3	Participants 242 339	chemotherapy for advanced measurable metastatic large bowel carcinoma, the response rate was 6/32
T4	Participants 402 449	median survival is 43 weeks for both treatments
T5	Participants 509 577	greater vomiting and hematologic toxicity than patients who received
